Events
Upcoming Events
SFARI Society for Neuroscience 2019 Social
Join the SFARI science team and leaders in the autism research community for an informal evening of food, drink, conversation and mingling on October 21, 2019, in Chicago.
Neuroimmune interactions shaping social behavior in mouse models for neurodevelopmental disorders
On October 30, 2019, Gloria Choi will discuss her work using mouse models of maternal immune activation to study the role of maternal infection in neurodevelopmental disorders, such as autism spectrum disorder.
Past Events
SFARI Society for Neuroscience 2018 Social
Join the SFARI science team and leaders in the autism research community for an informal evening of food, drink, conversation and mingling on 5 November 2018 in San Diego.
Thinking differently about neurodevelopmental disorders and autism: Lumping vs. splitting
Child Neurologist and Senior Clinician Scientist, Holland Bloorview Kids Rehabilitation Hospital
Associate Professor, Department of Pediatrics, University of Toronto
On September 26, 2018, Evdokia Anagnostou discussed the challenge of rethinking classification systems and diagnostic labels for autism and related neurodevelopmental disorders in light of recent findings from research and clinical studies.
Autism genetics: Where have we been and where are we going?
On April 10, 2018, Matthew State reviewed the progress that has been made in autism genetics over the past 10 years and the role that the Simons Simplex Collection (SSC) played in this (r)evolution. He also addressed the potential contribution of ongoing genomic studies including whole-genome sequencing as well as the challenges and opportunities of leveraging the genetic findings to identify pathophysiological mechanisms.
On the road to precision health: Brain-based biomarkers in autism spectrum disorder
Director, Developmental Neurophysiology Lab, Center for Autism Research and Treatment, University of California, Los Angeles
On 7 February 2018, Shafali Spurling Jeste provided a topical overview of the current state of research in autism biomarkers. She shared data from studies of autism biomarkers in three key areas: early risk prediction (studies of high-risk infants), heterogeneity within the autism spectrum and genetically defined subgroups within autism. Finally, she discussed the challenges around clinical trial design and development and considered how more objective measures of brain function can improve clinical trials.
Arousal, emotion regulation and challenging behaviors: Insights from the Autism Inpatient Collection
Vice President, Medical Affairs, Developmental Disorders Service, Maine Behavioral Healthcare
On 24 January 2018, Matthew Siegel drew upon a new resource, the Autism Inpatient Collection data set, to offer preliminary insights into the relationships between physiologic arousal, emotion dysregulation and the occurrence of challenging behaviors. Such behaviors may represent an attempt to modulate physiologic arousal in minimally verbal individuals with autism spectrum disorders.
Autism genetics: Searching for coherence
On 28 November 2017, Daniel Geschwind discussed his group’s use of RNA sequencing, chromatin structure and gene networks to help develop an understanding of potential convergent mechanisms in autism spectrum disorders.